clinical_trials
Valbenazine for Tardive Dyskinesia Tied to Less Antipsychotic Drop-Off
Confidence86·multiple reportsImportance88NP-EVT-20261109-ACA8CE6
(MedPage Today) -- Starting valbenazine (Ingrezza) to treat tardive dyskinesia might reduce antipsychotic discontinuation in patients newly diagnosed with the side effect, a retrospective cohort study of Medicare claims indicated. Among patients...
Read the original at the primary source
Valbenazine for Tardive Dyskinesia Tied to Less Antipsychotic Drop-Off
11/9/2026, 7:46:19 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —